BOSTON Scientific Corp, the second-largest maker of heart devices, raised its 2011 earnings forecast and reported a quarterly profit a year after withdrawing implantable defibrillators from the market.

BOSTON Scientific, the second-biggest heart-device maker, reported a fourth-quarter profit last night that beat analyst estimates on higher- than-expected sales.

Boston Scientific, which announced a €21.7m investment in its Cork plant last August, has reported an almost 40% fall in its second quarter earnings.